Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Metadata
Title
Outcome of type III Gaucher disease on enzyme replacement therapy: Review of 55 cases
Authors
E. H. Davies
A. Erikson
T. Collin-Histed
E. Mengel
A. Tylki-Szymanska
A. Vellodi
Publication date
01-11-2007
Published in
Journal of Inherited Metabolic Disease / Issue 6/2007
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-007-0577-z

Other articles of this Issue 6/2007

Journal of Inherited Metabolic Disease 6/2007 Go to the issue

Original Article

Depression in adults with Fabry disease: A common and under-diagnosed problem

Original Article

Elevated serum biotinidase activity in hepatic glycogen storage disorders–A convenient biomarker

Original Article

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia

Rapid Communication

Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome

Short Report

Osteoma of the calvaria in l-2-hydroxyglutaric aciduria

Short Report

Home treatment with enzyme replacement therapy for mucopolysaccharidosis type I is feasible and safe

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits